GSK Investigational Site

Royal Oak, Michigan 48073-6769

0 studies enrolling now · 11 studies all time

What they study most

Bipolar Disorder, Diabetes Mellitus, Type 2, Influenza, Human, Macular Degeneration, Metastatic Breast Cancer, Nausea and Vomiting, Postoperative, Neoplasms, Breast, Neoplasms, Prostate, Postoperative Nausea and Vomiting, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza — Completed
• Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed
• Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration — Completed
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide — Completed
• ARI103094-Follow-Up Study for REDUCE Study Subjects — Completed
• Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women — Completed
• Post-Operative Nausea And Vomiting Study In Female Patients — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Rosiglitazone on Microalbuminuria in Type 2 Diabetics — Completed
• Bipolar Study in Adults at Least 18 Years of Age — Completed
• Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. — Completed